Product correctly added to cart.

discount label
Fmoc-PEG8-NHS ester
View 3D

Biosynth logo

Fmoc-PEG8-NHS ester

CAS: 1334170-03-4

Ref. 3D-FN166632

10mg
136.00 €
25mg
138.00 €
50mg
194.00 €
100mg
310.00 €
250mg
453.00 €
Estimated delivery in United States, on Tuesday 11 Feb 2025

Product Information

Name:
Fmoc-PEG8-NHS ester
Description:

Fmoc-PEG8-NHS ester is a highly versatile compound used in pegylation processes. It is composed of N-hydroxysuccinimide (NHS) and an eight-unit polyethylene glycol (PEG) chain. This product is commonly used as a PEG linker for the modification of various biomolecules, such as proteins and peptides. The Fmoc group provides protection to the amine functionality, allowing for controlled and selective conjugation reactions. With its heterobifunctional nature, Fmoc-PEG8-NHS ester enables the coupling of molecules with different functional groups, expanding its applications in drug delivery systems, diagnostics, and bioconjugation chemistry. Its high purity and stability make it an ideal choice for researchers and scientists seeking reliable PEG products for their projects.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
760.82 g/mol
Formula:
C38H52N2O14
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FN166632 Fmoc-PEG8-NHS ester

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".